Wikiwand AI

5-Thiometaescaline

Pharmaceutical compound From Wikipedia, the free encyclopedia

5-Thiometaescaline (5-TME), also known as 3-ethoxy-4-methoxy-5-methylthiophenethylamine, is a psychoactive drug of the phenethylamine and scaline families related to mescaline.[1][2][3] It is the analogue of metaescaline in which the methoxy group at the 5 position has been replaced with a methylthio group.[1][2][3] The drug is one of three possible positional isomers of thiometaescaline (TME), the others being 3-thiometaescaline (3-TME) and 4-thiometaescaline (4-TME).[1][2][3]

Other names5-TME; 3-Ethoxy-4-methoxy-5-methylthiophenethylamine; 3-EtO-4-MeO-5-MeS-PEA
ATC code
  • None
Quick facts Clinical data, Other names ...
5-Thiometaescaline
Clinical data
Other names5-TME; 3-Ethoxy-4-methoxy-5-methylthiophenethylamine; 3-EtO-4-MeO-5-MeS-PEA
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 2-(3-ethoxy-4-methoxy-5-methylsulfanylphenyl)ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC12H19NO2S
Molar mass241.35 g·mol−1
3D model (JSmol)
  • CCOC1=C(C(=CC(=C1)CCN)SC)OC
  • InChI=1S/C12H19NO2S/c1-4-15-10-7-9(5-6-13)8-11(16-3)12(10)14-2/h7-8H,4-6,13H2,1-3H3
  • Key:BRABKKMYSDDDCR-UHFFFAOYSA-N
Close

In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 5-TME's dose as greater than 200 mg orally and its duration as unknown.[1][2] The effects of 5-TME have been reported to include possible tinnitus, a possible brush of lightheadedness, and nothing else, but these changes could not be clearly ascribed to the drug.[1]

The chemical synthesis of 5-TME has been described.[1][3]

5-TME was first described in the scientific literature by Alexander Shulgin and Peyton Jacob III in 1984.[3] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]

See also

References

Related Articles

Timelines

Top Qs

Fact Checks